<p>This study examined the tissue of patients who received oral pazopanib prior to nephrectomy. Patients were consented and underwent a pre-treatment biopsy. Pretreatment samples for analysis were preserved as available. Subjects underwent a proscribed course of treatment with pazopanib. At the completion of treatment, subjects underwent a planned nephrectomy, and samples were collected from the nephrectomy specimen. We recorded response to treatment, adverse events, and 2 year follow up for recurrence.</p>

Neoadjuvant Pazopanib in Renal Cell Carcinoma

Carcinoma, Renal Cell study with OTHER, RNA-Seq data on dbGaP (22 participants)